We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+16.79%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$20.1M
Cap. Flow
-$50.5M
Cap. Flow %
-27.06%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$2.53M
2
CTLT
CATALENT, INC.
CTLT
+$304K

Top Sells

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$30.4M
2
CYRX icon
CryoPort
CYRX
+$16.7M
3
CRL icon
Charles River Laboratories
CRL
+$4.15M
4
AZTA icon
Azenta
AZTA
+$2.18M

Sector Composition

Rank Sector Weight
1 Healthcare 98.95%
2 Industrials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.21B
$47.6M 25.52%
1,030,000
-45,000
-4% -$2.18M
CRL icon
2
Charles River Laboratories
CRL
$10.8B
$47.6M 25.47%
210,000
-20,000
-9% -$4.15M
BIO icon
3
Bio-Rad Laboratories Class A
BIO
$8.15B
$46.4M 24.85%
90,000
+5,000
+6% +$2.53M
CTLT
4
DELISTED
CATALENT, INC.
CTLT
$43.1M 23.11%
503,600
+3,600
+0.7% +$304K
CYRX icon
5
CryoPort
CYRX
$832M
$1.96M 1.05%
41,279
-411,693
-91% -$16.7M
BRKR icon
6
Bruker
BRKR
$8.86B
– –
-746,253
Closed -$30.4M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Tower House Partners held 6 positions worth $187M, down 9.7% from $207M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners withdrew a net $50.5M in Q3 2020, closing 1 position and reducing 3 holdings. Its most notable exit was Bruker, an estimated $30.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 93% a quarter earlier, followed by Industrials.

Against the trend, Tower House Partners added an estimated $2.53M to Bio-Rad Laboratories Class A.

  • Tower House Partners added most to Bio-Rad Laboratories Class A in Q3 2020, an estimated $2.53M increase.
  • Tower House Partners's biggest Q3 2020 reduction was CryoPort, cutting an estimated $16.7M.
  • Tower House Partners fully exited Bruker in Q3 2020, selling an estimated $30.4M.
  • Tower House Partners's ten largest holdings make up 100% of its $187M portfolio in Q3 2020.
  • Tower House Partners opened 0 new positions and closed 1 in Q3 2020.
  • Tower House Partners's portfolio value fell 9.7% quarter-over-quarter to $187M.

Based on Tower House Partners's 13F filing for Q3 2020, filed 16 Nov 2020.